JP2016086744A5 - - Google Patents

Download PDF

Info

Publication number
JP2016086744A5
JP2016086744A5 JP2014225642A JP2014225642A JP2016086744A5 JP 2016086744 A5 JP2016086744 A5 JP 2016086744A5 JP 2014225642 A JP2014225642 A JP 2014225642A JP 2014225642 A JP2014225642 A JP 2014225642A JP 2016086744 A5 JP2016086744 A5 JP 2016086744A5
Authority
JP
Japan
Prior art keywords
protein
gene encoding
genome
viral vector
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014225642A
Other languages
English (en)
Japanese (ja)
Other versions
JP6854461B2 (ja
JP2016086744A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2014225642A external-priority patent/JP6854461B2/ja
Priority to JP2014225642A priority Critical patent/JP6854461B2/ja
Priority to PCT/JP2015/081145 priority patent/WO2016072446A1/ja
Priority to CN201580068057.8A priority patent/CN107109436A/zh
Priority to US15/523,547 priority patent/US20170304430A1/en
Priority to KR1020177015408A priority patent/KR20200066748A/ko
Priority to EP15857426.9A priority patent/EP3216868A4/en
Publication of JP2016086744A publication Critical patent/JP2016086744A/ja
Publication of JP2016086744A5 publication Critical patent/JP2016086744A5/ja
Publication of JP6854461B2 publication Critical patent/JP6854461B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014225642A 2014-11-05 2014-11-05 ウイルスベクター、iPS細胞の作製方法およびコンストラクト Active JP6854461B2 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2014225642A JP6854461B2 (ja) 2014-11-05 2014-11-05 ウイルスベクター、iPS細胞の作製方法およびコンストラクト
KR1020177015408A KR20200066748A (ko) 2014-11-05 2015-11-05 바이러스 벡터, 세포 및 작제물
CN201580068057.8A CN107109436A (zh) 2014-11-05 2015-11-05 病毒载体、细胞及构建体
US15/523,547 US20170304430A1 (en) 2014-11-05 2015-11-05 Virus vector, cell, and construct
PCT/JP2015/081145 WO2016072446A1 (ja) 2014-11-05 2015-11-05 ウイルスベクター、細胞およびコンストラクト
EP15857426.9A EP3216868A4 (en) 2014-11-05 2015-11-05 Virus vector, cell, and construct

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014225642A JP6854461B2 (ja) 2014-11-05 2014-11-05 ウイルスベクター、iPS細胞の作製方法およびコンストラクト

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019113463A Division JP2019170393A (ja) 2019-06-19 2019-06-19 iPS細胞の作製方法

Publications (3)

Publication Number Publication Date
JP2016086744A JP2016086744A (ja) 2016-05-23
JP2016086744A5 true JP2016086744A5 (enExample) 2017-12-21
JP6854461B2 JP6854461B2 (ja) 2021-04-07

Family

ID=55909170

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014225642A Active JP6854461B2 (ja) 2014-11-05 2014-11-05 ウイルスベクター、iPS細胞の作製方法およびコンストラクト

Country Status (6)

Country Link
US (1) US20170304430A1 (enExample)
EP (1) EP3216868A4 (enExample)
JP (1) JP6854461B2 (enExample)
KR (1) KR20200066748A (enExample)
CN (1) CN107109436A (enExample)
WO (1) WO2016072446A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11318200B2 (en) * 2013-11-26 2022-05-03 Zoetis Services Llc Methods and compositions for induction of immune response
CA3038721A1 (en) 2016-09-30 2018-04-05 Mayo Foundation For Medical Education And Research Viral vectors for nuclear reprogramming
JP7462863B2 (ja) * 2019-04-15 2024-04-08 国立感染症研究所長 組換え麻疹ウイルスの増殖方法及び宿主細胞
CN110904232B (zh) * 2019-12-12 2022-05-27 上海东方肝胆外科医院 评估索拉非尼疗效的分子标记及其检测试剂盒
CA3244685A1 (en) * 2021-12-28 2025-06-13 Jcr Pharmaceuticals Co., Ltd. Fusion protein of anti-transferrin receptor antibody and physiologically active protein for safe gene therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS602058A (ja) 1983-06-15 1985-01-08 Mitsubishi Electric Corp 電機子の製造方法
AU2001266337A1 (en) * 2000-06-27 2002-01-08 Dnavec Research Inc. Virus vector for transferring gene into renal cells
WO2007007921A1 (ja) * 2005-07-13 2007-01-18 Kyushu University, National University Corporation 分節ゲノム型組換えモノネガウイルスベクター
CN102159710B (zh) * 2008-07-16 2015-09-02 生物载体株式会社 使用染色体非整合型病毒载体制造经初始化的细胞的方法
JP5908838B2 (ja) * 2010-08-30 2016-04-26 株式会社Idファーマ 多能性幹細胞を誘導するための組成物およびその使用
WO2012063817A1 (ja) * 2010-11-09 2012-05-18 独立行政法人産業技術総合研究所 末梢血単球由来多能性幹細胞作製方法
CN105916980B (zh) * 2013-09-24 2025-09-16 株式会社爱迪药业 用于改进诱导多能干细胞的效率的方法

Similar Documents

Publication Publication Date Title
EP4659816A3 (en) MODIFIED CAPSID PROTEINS FOR IMPROVED PARVOVIRUS VECTOR DELIVERY
MX391337B (es) Sistemas de replicón de arterivirus recombinantes y usos de estos.
MX390848B (es) Factor ix modificado, y composiciones, metodos y usos para la transferencia de genes a celulas, organos y tejidos.
MX2016010649A (es) Vector de virus adeno-asociado.
MX2019004499A (es) Sistemas de replicón de virus recombinante y usos de estos.
MX388739B (es) Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso.
EA201492202A1 (ru) Способ экспрессии гетерологичных белков с использованием рекомбинантного вирусного вектора с минус-нитью рнк
CL2019003842A1 (es) Vectores virales recombinantes con tropismo modificado y usos de estos para la introducción dirigida de material genético a células humanas.
SA517381912B1 (ar) "عناصر تنظيمية معدلة بعد الانتساخ لعلاج الالتهاب الكبدي pre
MX2018005392A (es) Acidos nucleicos modificados dirigidos a acidos nucleicos.
PE20160188A1 (es) Variantes aav y composiciones, metodos y usos para transferencia de gen a celulas, organos y tejidos
MX392639B (es) Vectores virales recombinantes para la integración de transgenes
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
WO2015155686A3 (en) Methods and compositions for rna-directed repression of transcription using crispr-associated genes
EA201891001A1 (ru) Вакцины на основе нуклеиновых кислот против вируса ветряной оспы (vzv)
BR112016017736A2 (pt) métodos e produtos para produção e distribuição de ácido nucleico
EP4043021A3 (en) Oncolytic tumor viruses and methods of use
DK3889166T3 (da) Rekombinante virale vektorer, der indeholder mindre væsentlige prrsv-proteiner, og fremgangsmåder til fremstilling og anvendelse deraf
MX375778B (es) Variantes mejoradas de enzimas.
CN109937252A (zh) 重组dna聚合酶
MX2020013959A (es) Mutantes de hemaglutinina del virus de la influenza.
PE20170941A1 (es) Genes de tolerancia a herbicidas y metodos para usar los mismos
JP2016519575A5 (enExample)
CO2017011431A2 (es) Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina
MX374934B (es) Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas.